Repare Therapeutics Inc. (RPTX) Tops Q2 EPS by 53c
Get Alerts RPTX Hot Sheet
Join SI Premium – FREE
Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q2 EPS of ($0.28), $0.53 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $30.25 million versus the consensus estimate of $7.01 million.
For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- New Break Resources plans $550,000 flow-through share offering
- Qualcomm shares fall on Intel warning and legal concerns
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share